Variant Creutzfeldt–Jakob disease and the Canadian blood system after the tainted blood tragedy

Abstract

The transfusion transmission of hepatitis C and HIV to thousands of Canadian blood recipients was one of this country's largest public health catastrophes. In response to this crisis, and in an effort to prevent such a tragedy from occurring again, the Canadian blood system has undergone substantial reform. Variant Creutzfeldt-Jakob (vCJD) disease was the first infectious threat faced by the blood system since undergoing reform. The response at the time to this risk provides insights into the Canadian blood system's new approach to infectious threats. Our analysis of the decision-making concerning vCJD identifies two dominant themes characterizing the new blood system's approach to safety: (1) the adoption of a precautionary approach to new risks which involves taking action in advance of definitive evidence, and (2) risk aversion amongst policy makers, which has contributed to the adoption of safety measures with comparatively high cost-effectiveness ratios. Overall the principles governing the new blood system have contributed to the system both providing protection against emerging infectious risks and regaining the confidence of the public and recipients. However, the current set of policy factors will likely contribute to increasingly risk-averse policy making that will contribute to continued increases in the cost of the blood system. The challenge the blood system now faces is to find the appropriate balance between maximizing safety and ensuring the system remains affordable.

Pandemic H1N1 in Canada and the use of evidence in developing public health policies – A policy analysis

“…We also allowed thematic content to evolve independently of Lomas' framework. The principal investigator (the primary rater) developed the coding guide based on the framework and adaptations from its use in a previous analysis (Wilson et al, 2007). The interviews were distributed between the primary and secondary rater for independent coding.…”

Why stay? Resilience in haemophilia physicians in the 1980s

“…The events of 1980s led to increasingly safe treatments in haemophilia, due to harnessing technology, increased state investment and lobbying to enable worldwide access to high quality care. Lessons from 1980s resulted in introduction of precautionary policies in response to transfusion‐transmitted vCJD 28. These responses were notable for reviews of precautionary policies based on emergent data from commissioned research; the costly nature of responses by blood services and the emphasis on policy rather than practice to address perceived threat 29.…”

Haemophilia prophylaxis: how can we justify the costs?

“…This principle (where harms are possible, action should be taken before scientific proof of harm has been established) appears to have been widely adopted by policy officials in an attempt to reduce risk [57]. When applied to the blood system, the precautionary principle – due to risk aversion on the part of policy makers – has resulted in the adoption of very costly measures [58]. The precautionary principle has been criticized on the basis that under it decision‐makers will make choices that are not necessarily good solutions, but rather ones that will protect them from litigation and accusations in the future [59].…”